Micropapillary Breast Carcinoma: From Molecular Pathogenesis to Prognosis

References

• Fisher ER, Gregorio R, Redmond C, Dekker A, Fisher B. Pathologic findings from the national surgical adjuvant breast project (protocol no. 4). II. The significance of regional node histology other than sinus histiocytosis in invasive mammary cancer. Am J Clin Pathol. 1976;65:21–30. doi:10.1093/ajcp/65.1.21
   PubMed Web of Science ®Google Scholar
• Invasive micropapillary carcinoma of the breast - PubMed. Available from: https://pubmed.ncbi.nlm.nih.gov/8302807/. Accessed May 16, 2021.
   Google Scholar
• Yang Y-L, Liu -B-B, Zhang X, Fu L. Invasive micropapillary carcinoma of the breast: an update. Arch Pathol Lab Med. 2016;140:799–805. doi:10.5858/arpa.2016-0040-RA
   PubMed Web of Science ®Google Scholar
• Stranix JT, Kwa MJ, Shapiro RL, Speyer JL. Invasive micropapillary carcinoma of the male breast: case report and review of the literature. Cancer Treat Commun. 2015;3:44–49. doi:10.1016/j.ctrc.2014.12.001
   Google Scholar
• Tanaka Y, Morishima I, Kikuchi K. Invasive micropapillary carcinomas arising 42 years after augmentation mammoplasty: a case report and literature review. World J Surg Oncol. 2008;6:1–5. doi:10.1186/1477-7819-6-33
   PubMed Web of Science ®Google Scholar
• Vingiani A, Maisonneuve P, Dell’Orto P, et al. The clinical relevance of micropapillary carcinoma of the breast: a case-control study. Histopathology. 2013;63:217–224. doi:10.1111/his.12147
   PubMed Web of Science ®Google Scholar
• Wu Y, Zhang N, Yang Q. The prognosis of invasive micropapillary carcinoma compared with invasive ductal carcinoma in the breast: a meta-analysis. BMC Cancer. 2017;17:1–9. doi:10.1186/s12885-017-3855-7
   PubMed Web of Science ®Google Scholar
• Coyle EA, Taj H, Comba I, Vasquez J, Zayat V. Invasive micropapillary carcinoma: a rare case of male breast cancer. Cureus. 2020;12:10–13. doi:10.7759/cureus.10571
   Web of Science ®Google Scholar
• Tsushimi T, Mori H, Harada T, Ikeda Y, Ohnishi H. Invasive micropapillary carcinoma of the breast in a male patient: report of a case. Int J Surg Case Rep. 2013;4:988–991. doi:10.1016/j.ijscr.2013.09.001
   PubMedGoogle Scholar
• Dong C-G, Yang Y-P, Zhu Y-L. Invasive micropapillary carcinoma of male breast with neuroendocrine differentiation: report of a case. Chin J Pathol. 2011;40:704–706. doi:10.3760/cma.j.issn.0529-5807.2011.10.016
   Google Scholar
• Marchiò C, Pietribiasi F, Castiglione R, Fusco N, Sapino A. “Giants in a microcosm”: multinucleated giant cells populating an invasive micropapillary carcinoma of the breast. Int J Surg Pathol. 2015;23:654–655. doi:10.1177/1066896915605616
   PubMed Web of Science ®Google Scholar
• Lui PCW, Lau PPL, Tse GMK, et al. Fine needle aspiration cytology of invasive micropapillary carcinoma of the breast. Pathology. 2007;39:401–405. doi:10.1080/00313020701444499
   PubMed Web of Science ®Google Scholar
• Tang S-L, Yang J-Q, Du Z-G, et al. Clinicopathologic study of invasive micropapillary carcinoma of the breast. Oncotarget. 2017;8:42455–42465. doi:10.18632/oncotarget.16405
   PubMedGoogle Scholar
• Cui Z-Q, Feng J-H, Zhao Y-J. Clinicopathological features of invasive micropapillary carcinoma of the breast. Oncol Lett. 2015;9:1163–1166. doi:10.3892/ol.2014.2806
   PubMed Web of Science ®Google Scholar
• Hashmi AA, Aijaz S, Mahboob R, et al. Clinicopathologic features of invasive metaplastic and micropapillary breast carcinoma: comparison with invasive ductal carcinoma of breast. BMC Res Notes. 2018;11:1–7. doi:10.1186/s13104-018-3623-z
   PubMedGoogle Scholar
• Pettinato G, Pambuccian SE, Di Prisco B, Manivel JC. Fine needle aspiration cytology of invasive micropapillary (pseudopapillary) carcinoma of the breast: report of 11 cases with clinicopathologic findings. Acta Cytol. 2002;46:1088–1094. doi:10.1159/000327112
   PubMed Web of Science ®Google Scholar
• Ongürü O, Deveci S, Günhan O, Öngürü Ö, Deveci S, Günhan Ö. Cytological findings of invasive micropapillary carcinoma of the breast: a report of two cases. Cytopathology. 2002;13:160–163. doi:10.1046/j.1365-2303.2002.00390.x
   PubMed Web of Science ®Google Scholar
• Madakshira MG, Saikia UN. Neutrophilic emperipolesis in micropapillary carcinoma breast. Breast J. 2020;26:539–540. doi:10.1111/tbj.13563
   PubMed Web of Science ®Google Scholar
• Troxell ML. Reversed MUC1/EMA polarity in both mucinous and micropapillary breast carcinoma. Hum Pathol. 2014;45:432–434. doi:10.1016/j.humpath.2013.08.026
   PubMed Web of Science ®Google Scholar
• Sun P, Zhong Z, Lu Q, et al. Mucinous carcinoma with micropapillary features is morphologically, clinically and genetically distinct from pure mucinous carcinoma of breast. Mod Pathol. 2020;33:1945–1960. doi:10.1038/s41379-020-0554-8
   PubMed Web of Science ®Google Scholar
• Li YS, Kaneko M, Sakamoto DG, Takeshima Y, Inai K. The reversed apical pattern of MUC1 expression is characteristics of invasive micropapillary carcinoma of the breast. Breast Cancer. 2006;13:58–63. doi:10.2325/jbcs.13.58
   PubMedGoogle Scholar
• Akiyoshi T, Nagaie T, Tokunaga M, et al. Invasive micropapillary carcinoma of the breast with minimal regional lymph node metastasis regardless of the huge size: report of a case. Breast Cancer. 2003;10:356–360. doi:10.1007/BF02967657
   PubMedGoogle Scholar
• Chen H, Wu K, Wang M, Wang F, Zhang M, Zhang P. Invasive micropapillary carcinoma of the breast has a better long-term survival than invasive ductal carcinoma of the breast in spite of its aggressive clinical presentations: a comparison based on large population database and case–control analysis. Cancer Med. 2017;6:2775–2786. doi:10.1002/cam4.1227
   PubMed Web of Science ®Google Scholar
• Mayer AP, Greenberg ML. FNB diagnosis of breast carcinoma associated with HIV infection: a case report and review of HIV associated malignancy. Pathology. 1996;28:90–95. doi:10.1080/00313029600169623
   PubMed Web of Science ®Google Scholar
• Lai PC, Chiu TH, Huang YT. Overexpression of BDNF and TrkB in human. Anticancer Res. 2010;31:1265–1270.
   Google Scholar
• Kamitani K, Kamitani T, Ono M, Toyoshima S, Mitsuyama S. Ultrasonographic findings of invasive micropapillary carcinoma of the breast: correlation between internal echogenicity and histological findings. Breast Cancer. 2012;19:349–352. doi:10.1007/s12282-011-0293-2
   PubMed Web of Science ®Google Scholar
• Fowler AM, Andersen J, Conway PD. Local recurrence of invasive micropapillary breast cancer after mammosite brachytherapy: a case report and literature review. Clin Breast Cancer. 2009;9:253–257. doi:10.3816/CBC.2009.n.043
   PubMed Web of Science ®Google Scholar
• Yu JI, Choi DH, Huh SJ, et al. Differences in prognostic factors and failure patterns between invasive micropapillary carcinoma and carcinoma with micropapillary component versus invasive Ductal carcinoma of the breast: retrospective multicenter case-control study (KROG 13-06). Clin Breast Cancer. 2015;15:353–361.e2. doi:10.1016/j.clbc.2015.01.008
   PubMed Web of Science ®Google Scholar
• Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372. doi:10.1136/BMJ.N71
   Web of Science ®Google Scholar
• Zekioglu O, Erhan Y, Çiris M, Bayramoglu H, Özdemir N. Invasive micropapillary carcinoma of the breast: high incidence of lymph node metastasis with extranodal extension and its immunohistochemical profile compared with invasive ductal carcinoma. Histopathology. 2004;44:18–23. doi:10.1111/j.1365-2559.2004.01757.x
   PubMed Web of Science ®Google Scholar
• Nassar H. Carcinomas with micropapillary morphology: clinical significance and current concepts. Adv Anat Pathol. 2004;11:297–303. doi:10.1097/01.pap.0000138142.26882.fe
   PubMed Web of Science ®Google Scholar
• Chen AC, Paulino AC, Schwartz MR, et al. Population-based comparison of prognostic factors in invasive micropapillary and invasive ductal carcinoma of the breast. Br J Cancer. 2014;111:619–622. doi:10.1038/bjc.2014.301
   PubMed Web of Science ®Google Scholar
• Gokce H, Durak MG, Akin MM, et al. Invasive micropapillary carcinoma of the breast: a clinicopathologic study of 103 cases of an unusual and highly aggressive variant of breast carcinoma. Breast J. 2013;19:374–381. doi:10.1111/tbj.12128
   PubMed Web of Science ®Google Scholar
• Taketani K, Tokunaga E, Yamashita N, et al. A case of invasive micropapillary carcinoma of the breast involving extensive lymph node metastasis. World J Surg Oncol. 2014;12:1–6. doi:10.1186/1477-7819-12-84
   PubMed Web of Science ®Google Scholar
• Lezid Á, Rodríguez P. Carcinoma micropapilarinvasor, una varianteagresiva de carcinoma de glándulamamaria. Revisión a propósito de 12 casos [Invasive micropapillary carcinoma, an aggressive variant of mammary gland carcinoma. Review of 12 cases]. Patol Rev Latinoam. 2008;46(3):215–221. Spanish.
   Google Scholar
• Middleton LP, Tressera F, Sobel ME, et al. Infiltrating micropapillary carcinoma of the breast. Mod Pathol. 1999;12:499–504.
   PubMed Web of Science ®Google Scholar
• Moorman AM, Vink R, Rutgers EJT, Kouwenhoven EA. Incidence, clinical features, and outcomes of special types in breast cancer in a single institution population. Breast J. 2020;26:2163–2169. doi:10.1111/tbj.14069
   PubMed Web of Science ®Google Scholar
• Akdeniz N, Kaplan MA, Küçüköner M, et al. Rare breast cancer types: a study about characteristics, outcomes, and peculiarities. J Oncol Sci. 2020;6:164–172. doi:10.37047/jos.2020-78231
   Google Scholar
• Kaygusuz EI, Cetiner H, Yavuz H. Clinico-pathological significance of extra-nodal spread in special types of breast cancer. Cancer Biol Med. 2014;11:116–122. doi:10.7497/j.issn.2095-3941.2014.02.006
   PubMedGoogle Scholar
• Zheng L, Liu J-T, Wei L-J. Clinicopathological analysis of 104 cases of invasive micropapillary breast carcinoma. J Pract Oncol. 2010;25:184–187.
   Google Scholar
• Lewis GD, Xing Y, Haque W, et al. The impact of molecular status on survival outcomes for invasive micropapillary carcinoma of the breast. Breast J. 2019;25:1171–1176. doi:10.1111/tbj.13432
   PubMed Web of Science ®Google Scholar
• Ye F-G, Xia C, Ma D, Lin P-Y, Hu X, Shao Z-M. Nomogram for predicting preoperative lymph node involvement in patients with invasive micropapillary carcinoma of breast: a SEER population-based study. BMC Cancer. 2018;18. doi:10.1186/s12885-018-4982-5
   Web of Science ®Google Scholar
• Paterakos M, Watkin WG, Edgerton SM, et al. Invasive micropapillary carcinoma of the breast: a prognostic study. Hum Pathol. 1999;30:1459–1463. doi:10.1016/S0046-8177(99)90168-5
   PubMed Web of Science ®Google Scholar
• Hao S, Zhao Y, Peng J, et al. Invasive micropapillary carcinoma of the breast had no difference in prognosis compared with invasive ductal carcinoma: a propensity-matched analysis. Sci Rep. 2019;9:1–8. doi:10.1038/s41598-018-36362-8
   PubMed Web of Science ®Google Scholar
• Ye F, Yu P, Li N, et al. Prognosis of invasive micropapillary carcinoma compared with invasive ductal carcinoma in breast: a meta-analysis of PSM studies. Breast. 2020;51:11–20. doi:10.1016/j.breast.2020.01.041
   PubMed Web of Science ®Google Scholar
• De La Cruz C, Moriya T, Endoh M, et al. Invasive micropapillary carcinoma of the breast: clinicopathological and immunohistochemical study. Pathol Int. 2004;54:90–96. doi:10.1111/j.1440-1827.2004.01590.x
   PubMed Web of Science ®Google Scholar
• Chen AC, Paulino AC, Schwartz MR, et al. Prognostic markers for invasive micropapillary carcinoma of the breast: a population-based analysis. Clin Breast Cancer. 2013;13:133–139. doi:10.1016/j.clbc.2012.10.001
   PubMed Web of Science ®Google Scholar
• Kaya C, Uçak R, Bozkurt E, et al. The impact of micropapillary component ratio on the prognosis of patients with invasive micropapillary breast carcinoma. J Investig Surg. 2020;33:31–39. doi:10.1080/08941939.2018.1474302
   PubMed Web of Science ®Google Scholar
• Luna-Moré S, Casquero S, Pérez-Mellado A, Rius F, Weil B, Gornemann I. Importance of estrogen receptors for the behavior of invasive micropapillary carcinoma of the breast. Review of 68 cases with follow-up of 45. Pathol Res Pract. 2000;196:35–39. doi:10.1016/S0344-0338(00)80019-9
   PubMed Web of Science ®Google Scholar
• Mahe E, Farag M, Boutross-Tadross O. Invasive micropapillary breast carcinoma: a retrospective study of classification by pathological parameters. Malays J Pathol. 2013;35:133–138.
   PubMed Web of Science ®Google Scholar
• Kuroda H, Sakamoto G, Ohnisi K, Itoyama S. Overexpression of her2/neu, estrogen and progesterone receptors in invasive micropapillary carcinoma of the breast. Breast Cancer. 2004;11:301–305. doi:10.1007/BF02984553
   PubMedGoogle Scholar
• Walsh MM, Bleiweiss IJ. Invasive micropapillary carcinoma of the breast: eighty cases of an underrecognized entity. Hum Pathol. 2001;32:583–589. doi:10.1053/hupa.2001.24988
   PubMed Web of Science ®Google Scholar
• Li W, Han Y, Wang C, et al. Precise pathologic diagnosis and individualized treatment improve the outcomes of invasive micropapillary carcinoma of the breast: a 12-year prospective clinical study. Mod Pathol. 2018;31:956–964. doi:10.1038/s41379-018-0024-8
   PubMed Web of Science ®Google Scholar
• Stewart RL, Caron JE, Gulbahce EH, Factor RE, Geiersbach KB, Downs-Kelly E. HER2 immunohistochemical and fluorescence in situ hybridization discordances in invasive breast carcinoma with micropapillary features. Mod Pathol. 2017;30:1561–1566. doi:10.1038/modpathol.2017.65
   PubMed Web of Science ®Google Scholar
• Bandyopadhyay S, Bluth MH, Ali-Fehmi R. Breast carcinoma: updates in molecular profiling 2018. Clin Lab Med. 2018;38:401–420. doi:10.1016/j.cll.2018.02.006
   PubMed Web of Science ®Google Scholar
• Min SY, Jung E-J, Seol H, Park IA. Cancer subtypes of breast carcinoma with micropapillary and mucinous component based on immunohistochemical profile. Korean J Pathol. 2011;45:125–131. doi:10.4132/KoreanJPathol.2011.45.2.125
   Google Scholar
• Nassar H, Wallis T, Andea A, Dey J, Adsay V, Visscher D. Clinicopathologic analysis of invasive micropapillary differentiation in breast carcinoma. Mod Pathol. 2001;14:836–841. doi:10.1038/modpathol.3880399
   PubMed Web of Science ®Google Scholar
• Kim J, Kim JY, Lee H-B, et al. Characteristics and prognosis of 17 special histologic subtypes of invasive breast cancers according to World Health Organization classification: comparative analysis to invasive carcinoma of no special type. Breast Cancer Res Treat. 2020;184:527–542. doi:10.1007/s10549-020-05861-6
   PubMed Web of Science ®Google Scholar
• Aggarwal G, Reid MD, Sharma S. Metaplastic variant of invasive micropapillary breast carcinoma: a unique triple negative phenotype. Int J Surg Pathol. 2012;20:488–493. doi:10.1177/1066896912436552
   PubMed Web of Science ®Google Scholar
• Varga Z, Zhao J, Öhlschlegel C, Odermatt B, Heitz PU. Preferential HER-2/neu overexpression and/or amplification in aggressive histological subtypes of invasive breast cancer. Histopathology. 2004;44:332–338. doi:10.1111/j.1365-2559.2004.01843.x
   PubMed Web of Science ®Google Scholar
• Mercogliano MF, Inurrigarro G, De Martino M, et al. Invasive micropapillary carcinoma of the breast overexpresses MUC4 and is associated with poor outcome to adjuvant trastuzumab in HER2-positive breast cancer. BMC Cancer. 2017;17:1–8. doi:10.1186/s12885-017-3897-x
   PubMed Web of Science ®Google Scholar
• Perron M, Wen HY, Hanna MG, Brogi E, Ross DS. HER2 immunohistochemistry in invasive micropapillary breast carcinoma: complete assessment of an incomplete pattern. Arch Pathol Lab Med. 2020. doi:10.5858/arpa.2020-0288-oa
   Web of Science ®Google Scholar
• Zhou S, Yang F, Bai Q, et al. Intense basolateral membrane staining indicates HER2 positivity in invasive micropapillary breast carcinoma. Mod Pathol. 2020;33:1275–1286. doi:10.1038/s41379-020-0461-z
   PubMed Web of Science ®Google Scholar
• Zouine S, Orfi Z, Kojok K, et al. Immunohistochemical and genetic exploration of incompatible A blood group antigen expression in invasive micropapillary breast carcinoma: a case report. Curr Res Transl Med. 2017;65:71–76. doi:10.1016/j.retram.2017.05.002
   PubMed Web of Science ®Google Scholar
• Lin Y, Duan Q, Yang Y, Zhu Y, Zhang J, Dong C. Immunohistochemistry of phosphatase and tensin homolog and metalloproteinase-9 in breast invasive micropapillary carcinoma. Eur J Gynaecol Oncol. 2019;40:380–383. doi:10.12892/ejgo4735.2019
   Web of Science ®Google Scholar
• Lü F, Zhang Y-Q, Guo X-J, Qian X-L, Li Y-Q, Fu L. Expression of integrin β1 and Kindlin-2 in invasive micropapillary carcinoma of the breast. Chin J Cancer Prev Treat. 2015;22:929–935.
   Google Scholar
• Gong Y, Sun X, Wiley EL, Rao MS. Expression of cell adhesion molecules, CD44s and E-cadherin, in infiltrating micropapillary versus tubular carcinomas of the breast. Breast Cancer Res Treat. 2001;69:295.
   Web of Science ®Google Scholar
• Liu B, Zheng X, Meng F, et al. Overexpression of β1 integrin contributes to polarity reversal and a poor prognosis of breast invasive micropapillary carcinoma. Oncotarget. 2018;9:4338–4353. doi:10.18632/oncotarget.22774
   PubMedGoogle Scholar
• Badyal RK, Bal A, Das A, Singh G. Invasive micropapillary carcinoma of the breast: immunophenotypic analysis and role of cell adhesion molecules (CD44 and E-Cadherin) in nodal metastasis. Appl Immunohistochem Mol Morphol. 2016;24:151–158. doi:10.1097/PAI.0000000000000167
   PubMedGoogle Scholar
• Huang L, Ji H, Yin L, et al. High expression of plakoglobin promotes metastasis in invasive micropapillary carcinoma of the breast via tumor cluster formation. J Cancer. 2019;10:2800–2810. doi:10.7150/jca.31411
   PubMed Web of Science ®Google Scholar
• Cui L-F, Guo X-J, Wei J, et al. Significance of interleukin-1β expression and microvascular density in invasive micropapillary carcinoma of breast. Chin J Pathol. 2008;37:599–603.
   Google Scholar
• Nagi C, Guttman M, Jaffer S, et al. N-cadherin expression in breast cancer: correlation with an aggressive histologic variant - Invasive micropapillary carcinoma. Breast Cancer Res Treat. 2005;94:225–235. doi:10.1007/s10549-005-7727-5
   PubMed Web of Science ®Google Scholar
• Liu F, Lang R, Wei J, et al. Increased expression of SDF-1/CXCR4 is associated with lymph node metastasis of invasive micropapillary carcinoma of the breast. Histopathology. 2009;54:741–750. doi:10.1111/j.1365-2559.2009.03289.x
   PubMed Web of Science ®Google Scholar
• Sun X, Gong Y, Wiley EL, Rao MS. Microvessel density is higher in invasive micropapillary carcinoma than in tubular carcinoma of the breast. Breast Cancer Res Treat. 2001;69:254.
   Web of Science ®Google Scholar
• Fan Y, Lang RG, Wang Y, Sun BC, Fu L. Relationship between expression of cell adhesion molecules and metastatic potential in invasive micropapillary carcinoma of breast. Zhonghua Bing Li Xue Za Zhi. 2004;33:308–311.
   PubMedGoogle Scholar
• Nosaka K, Makishima K, Sakabe T, et al. Upregulation of glucose and amino acid transporters in micropapillary carcinoma. Histol Histopathol. 2019;34:1009–1014. doi:10.14670/HH-18-099
   PubMed Web of Science ®Google Scholar
• Doublier S, Belisario DC, Polimeni M, et al. HIF-1 activation induces doxorubicin resistance in MCF7 3-D spheroids via P-glycoprotein expression: a potential model of the chemo-resistance of invasive micropapillary carcinoma of the breast. BMC Cancer. 2012;12. doi:10.1186/1471-2407-12-4
   PubMed Web of Science ®Google Scholar
• Li W, Liu F, Lei T, et al. The clinicopathological significance of CD44+/CD24-/low and CD24+ tumor cells in invasive micropapillary carcinoma of the breast. Pathol Res Pract. 2010;206:828–834. doi:10.1016/j.prp.2010.09.008
   PubMed Web of Science ®Google Scholar
• Simonetti S, Terracciano L, Zlobec I, et al. Immunophenotyping analysis in invasive micropapillary carcinoma of the breast: role of CD24 and CD44 isoforms expression. Breast. 2012;21:165–170. doi:10.1016/j.breast.2011.09.004
   PubMed Web of Science ®Google Scholar
• Umeda T, Ishida M, Murata S, et al. Immunohistochemical analyses of CD44 variant isoforms in invasive micropapillary carcinoma of the breast: comparison with a concurrent conventional invasive carcinoma of no special type component. Breast Cancer. 2016;23:869–875. doi:10.1007/s12282-015-0653-4
   PubMed Web of Science ®Google Scholar
• Li W, Yang D, Wang S, et al. Increased expression of CD146 and microvessel density (MVD) in invasive micropapillary carcinoma of the breast: comparative study with invasive ductal carcinoma-not otherwise specified. Pathol Res Pract. 2011;207:739–746. doi:10.1016/j.prp.2011.09.009
   PubMed Web of Science ®Google Scholar
• Kramer Z, Kenessey I, Gángó A, Lendvai G, Kulka J, Tőkés AM. Cell polarity and cell adhesion associated gene expression differences between invasive micropapillary and no special type breast carcinomas and their prognostic significance. Sci Rep. 2021;11(1):18484. doi:10.1038/s41598-021-97347-8
   PubMed Web of Science ®Google Scholar
• Li S, Yang C, Zhai L, et al. Deep sequencing reveals small RNA characterization of invasive micropapillary carcinomas of the breast. Breast Cancer Res Treat. 2012;136:77–87. doi:10.1007/s10549-012-2166-6
   PubMed Web of Science ®Google Scholar
• Le zhang YW, Zhang L, Xing H, et al. Invasive micropapillary carcinoma with cep17 monosomy of the bilateral breast: a rare case report and review of the literature. Onco Targets Ther. 2020;13:6425–6432. doi:10.2147/OTT.S251934
   PubMed Web of Science ®Google Scholar
• Gruel N, Benhamo V, Bhalshankar J, et al. Polarity gene alterations in pure invasive micropapillary carcinomas of the breast. Breast Cancer Res. 2014;16. doi:10.1186/bcr3653
   PubMed Web of Science ®Google Scholar
• Denisov EV, Skryabin NA, Vasilyev SA, et al. Relationship between morphological and cytogenetic heterogeneity in invasive micropapillary carcinoma of the breast: a report of one case. J Clin Pathol. 2015;68:758–762. doi:10.1136/jclinpath-2015-203009
   PubMed Web of Science ®Google Scholar
• Thor AD, Eng C, Devries S, et al. Invasive micropapillary carcinoma of the breast is associated with chromosome 8 abnormalities detected by comparative genomic hybridization. Hum Pathol. 2002;33:628–631. doi:10.1053/hupa.2002.124034
   PubMed Web of Science ®Google Scholar
• Pareja F, Ferrando L, Lee SSK, et al. The genomic landscape of metastatic histologic special types of invasive breast cancer. Npj Breast Cancer. 2020;6. doi:10.1038/s41523-020-00195-4
   Web of Science ®Google Scholar
• Marchiò C, Iravani M, Natrajan R, et al. Genomic and immunophenotypical characterization of pure micropapillary carcinomas of the breast. J Pathol. 2008;215:398–410. doi:10.1002/path.2368
   PubMed Web of Science ®Google Scholar
• Wang -X-X, Liu -B-B, Wu X, Su D, Zhu Z, Fu L. Loss of Leucine Zipper Putative Tumor Suppressor 1 (LZTS1) expression contributes to lymph node metastasis of breast invasive micropapillary carcinoma. Pathol Oncol Res. 2015;21:1021–1026. doi:10.1007/s12253-015-9923-x
   PubMed Web of Science ®Google Scholar
• Castellano I, Marchiò C, Tomatis M, et al. Micropapillary ductal carcinoma in situ of the breast: an inter-institutional study. Mod Pathol. 2010;23:260–269. doi:10.1038/modpathol.2009.169
   PubMed Web of Science ®Google Scholar
• Guerrieri C, Hudacko R. Tubulopapillary carcinoma: an aggressive variant of invasive breast carcinoma with a micropapillary DCIS-like morphology. Int J Surg Pathol. 2020;28:536–540. doi:10.1177/1066896919892699
   PubMed Web of Science ®Google Scholar
• Ide Y, Horii R, Osako T, et al. Clinicopathological significance of invasive micropapillary carcinoma component in invasive breast carcinoma. Pathol Int. 2011;61:731–736. doi:10.1111/j.1440-1827.2011.02735.x
   PubMed Web of Science ®Google Scholar
• Chen L, Fan Y, Lang R-G, Guo X-J, Sun Y-L, Fu L. Diagnosis and prognosis study of breast carcinoma with micropapillary component. Chin J Pathol. 2007;36:228–232.
   Google Scholar
• Bomeisl PE, Thompson CL, Harris LN, Gilmore HL. Comparison of oncotype DX recurrence score by histologic types of breast carcinoma. Arch Pathol Lab Med. 2015;139:1546–1549. doi:10.5858/arpa.2014-0557-OA
   PubMed Web of Science ®Google Scholar
• Perez AA, Balabram D, Salles MA, Gobbi H. Ductal carcinoma in situ of the breast: correlation between histopathological features and age of patients. Diagn Pathol. 2014;9:227. doi:10.1186/s13000-014-0227-3
   PubMed Web of Science ®Google Scholar
• Evers K. Significance of finding micropapillary DCIS on core needle biopsy. Acad Radiol. 2011;18:795–796. doi:10.1016/j.acra.2011.05.001
   PubMed Web of Science ®Google Scholar
• Lee YS, Mathew J, Dogan BE, Resetkova E, Huo L, Yang WT. Imaging features of micropapillary DCIS: correlation with clinical and histopathological findings. Acad Radiol. 2011;18:797–803. doi:10.1016/j.acra.2011.01.022
   PubMed Web of Science ®Google Scholar
• Kuba S, Ohtani H, Yamaguchi J, et al. Incomplete inside-out growth pattern in invasive breast carcinoma: association with lymph vessel invasion and recurrence-free survival. Virchows Arch. 2011;458:159–169. doi:10.1007/s00428-010-1033-2
   PubMed Web of Science ®Google Scholar
• Guo X, Chen L, Lang R, Fan Y, Zhang X, Fu L. Invasive micropapillary carcinoma of the breast: association of pathologic features with lymph node metastasis. Am J Clin Pathol. 2006;126:740–746. doi:10.1309/AXYY4AJTMNW6FRMW
   PubMed Web of Science ®Google Scholar
• Guan X, Xu G, Shi A, et al. Comparison of clinicopathological characteristics and prognosis among patients with pure invasive ductal carcinoma, invasive ductal carcinoma coexisted with invasive micropapillary carcinoma, and invasive ductal carcinoma coexisted with ductal carcinoma. Medicine (Baltimore). 2020;99:e23487. doi:10.1097/MD.0000000000023487
   PubMed Web of Science ®Google Scholar
• Kim M-J, Gong G, Joo HJ, Ahn S-H, Ro JY. Immunohistochemical and clinicopathologic characteristics of invasive ductal carcinoma of breast with micropapillary carcinoma component. Arch Pathol Lab Med. 2005;129:1277–1282. doi:10.5858/2005-129-1277-IACCOI
   PubMed Web of Science ®Google Scholar
• Ranade AC, Batra R, Sandhu G, Chitale RA, Balderacchi J. Clinicopathological evaluation of 100 cases of mucinous carcinoma of breast with emphasis on axillary staging and special reference to a micropapillary pattern. J Clin Pathol. 2010;63:1043–1047. doi:10.1136/jcp.2010.082495
   PubMed Web of Science ®Google Scholar
• Lim GH, Yan Z, Gudi M. Diagnostic dilemma of micropapillary variant of mucinous breast cancer. BMJ Case Rep. 2018;2018. doi:10.1136/bcr-2018-225775
   Google Scholar
• Shet T, Chinoy R. Presence of a micropapillary pattern in mucinous carcinomas of the breast and its impact on the clinical behavior. Breast J. 2008;14:412–420. doi:10.1111/j.1524-4741.2008.00616.x
   PubMed Web of Science ®Google Scholar
• Bal A, Joshi K, Sharma SC, Das A, Verma A, Wig JD. Prognostic significance of micropapillary pattern in pure mucinous carcinoma of the breast. Int J Surg Pathol. 2008;16:251–256. doi:10.1177/1066896908314784
   PubMed Web of Science ®Google Scholar
• Barbashina V, Corben AD, Akram M, Vallejo C, Tan LK. Mucinous micropapillary carcinoma of the breast: an aggressive counterpart to conventional pure mucinous tumors. Hum Pathol. 2013;44:1577–1585. doi:10.1016/j.humpath.2013.01.003
   PubMed Web of Science ®Google Scholar
• Collins K, Ricci A. Micropapillary variant of mucinous breast carcinoma: a distinct subtype. Breast J. 2018;24:339–342. doi:10.1111/tbj.12935
   PubMed Web of Science ®Google Scholar
• Asano Y, Kashiwagi S, Nagamori M, et al. Pure Mucinous Breast Carcinoma with Micropapillary Pattern (MUMPC): a case report. Case Rep Oncol. 2019;12:554–559. doi:10.1159/000501766
   PubMed Web of Science ®Google Scholar
• Kim H-J, Park K, Kim JY, Kang G, Gwak G, Park I. Prognostic significance of a micropapillary pattern in pure mucinous carcinoma of the breast: comparative analysis with micropapillary carcinoma. J Pathol Transl Med. 2017;51:403–409. doi:10.4132/jptm.2017.03.18
   PubMed Web of Science ®Google Scholar
• Doval DC, Tripathi R, Pasricha S, Goyal P, Agrawal C, Mehta A. HER2 positive mucinous carcinoma of breast with micropapillary features: report of a case and review of literature. Hum Pathol Case Rep. 2021;25:200531. doi:10.1016/j.ehpc.2021.200531
   Google Scholar
• Pareja F, Selenica P, Brown DN, et al. Micropapillary variant of mucinous carcinoma of the breast shows genetic alterations intermediate between those of mucinous carcinoma and micropapillary carcinoma. Histopathology. 2019;75:139–145. doi:10.1111/his.13853
   PubMed Web of Science ®Google Scholar
• Lin H-Y, Gao L-X, Jin M-L, Ding H-Y. Clinicopathologic features of micropapillary variant of pure mucinous carcinoma of breast. Chin J Pathol. 2012;41:613–617. doi:10.3760/cma.j.issn.0529-5807.2012.09.009
   Google Scholar
• Jiménez-Ayala M. Micropapillary carcinoma and mucinous carcinoma with a micropapillary pattern. Acta Cytol. 2007;51:1–2. doi:10.1159/000325673
   PubMed Web of Science ®Google Scholar
• Xu X, Bi R, Shui R, et al. Micropapillary pattern in pure mucinous carcinoma of the breast – does it matter or not? Histopathology. 2019;74:248–255. doi:10.1111/his.13722
   PubMed Web of Science ®Google Scholar
• Xu M, Ye M-N, Wang C, Ye H. Clinicopathological observation of breast micropapillary pure mucinous carcinoma combined with invasive micropapillary carcinoma. J Shanghai Jiaotong Univ. 2015;35:549–553.
   Google Scholar
• Günhan-Bilgen I, Zekioglu O, Üstün EE, Memis A, Erhan Y. Invasive micropapillary carcinoma of the breast: clinical, mammographic, and sonographic findings with histopathologic correlation. Am J Roentgenol. 2002;179:927–931. doi:10.2214/ajr.179.4.1790927
   PubMed Web of Science ®Google Scholar
• Adrada B, Arribas E, Gilcrease M, Yang WT. Invasive micropapillary carcinoma of the breast: mammographic, sonographic, and MRI features. Am J Roentgenol. 2009;193:58–63. doi:10.2214/AJR.08.1537
   Web of Science ®Google Scholar
• Yun SU, Choi BB, Shu KS, et al. Imaging findings of invasive micropapillary carcinoma of the breast. J Breast Cancer. 2012;15:57–64. doi:10.4048/jbc.2012.15.1.57
   PubMed Web of Science ®Google Scholar
• Kubota K, Ogawa Y, Nishioka A, et al. Radiological imaging features of invasive micropapillary carcinoma of the breast and axillary lymph nodes. Oncol Rep. 2008;20:1143–1147. doi:10.3892/or_00000122
   PubMed Web of Science ®Google Scholar
• Bandyopadhyay S, Ali-Fehmi R. Breast carcinoma. molecular profiling and updates. Clin Lab Med. 2013;33:891–909. doi:10.1016/j.cll.2013.08.009
   PubMed Web of Science ®Google Scholar
• Alsharif S, Daghistani R, Kamberoǧlu EA, Omeroglu A, Meterissian S, Mesurolle B. Mammographic, sonographic and MR imaging features of invasive micropapillary breast cancer. Eur J Radiol. 2014;83:1375–1380. doi:10.1016/j.ejrad.2014.05.003
   PubMed Web of Science ®Google Scholar
• Romero C, Carreira C, Urbasos M, Martín J, Lombardía J, García E. Carcinoma intraductal micropapilaren un varón con microcalcificaciones como único hallazgo radiológico [Intraductal micropapillary carcinoma in a male patient exhibiting microcalcification as sole radiological finding]. Radiologia. 2003;45:273–275. doi:10.1016/s0033-8338(03)77920-x
   Google Scholar
• Yoon GY, Cha JH, Kim HH, Shin HJ, Chae EY, Choi WJ. Comparison of invasive micropapillary and invasive ductal carcinoma of the breast: a matched cohort study. Acta Radiol. 2019;60:1405–1413. doi:10.1177/0284185119834689
   PubMed Web of Science ®Google Scholar
• Rhee SJ, Han B-K, Ko EY, Shin JH. Invasive micropapillary carcinoma of the breast: mammographic, sonographic and MR imaging findings. J Korean Soc Magn Reson Med. 2012;16(3):205–216. doi:10.13104/jksmrm.2012.16.3.205
   Google Scholar
• Michael M, Garzoli E, Reiner CS. Mammography, sonography and MRI for detection and characterization of invasive lobular carcinoma of the breast. Breast Dis. 2008;30:21–30. doi:10.3233/BD-2009-0279
   PubMedGoogle Scholar
• Kim SH, Cha ES, Park CS, et al. Imaging features of invasive lobular carcinoma: comparison with invasive ductal carcinoma. Jpn J Radiol. 2011;29(7):475–482. doi:10.1007/s11604-011-0584-8
   PubMed Web of Science ®Google Scholar
• Jones KN, Guimaraes LS, Reynolds CA, Ghosh K, Degnim AC, Glazebrook KN. Invasive micropapillary carcinoma of the breast: imaging features with clinical and pathologic correlation. Am J Roentgenol. 2013;200:689–695. doi:10.2214/AJR.12.8512
   PubMed Web of Science ®Google Scholar
• Mizushima Y, Yamaguchi R, Yokoyama T, Ogo E, Nakashima O. Recurrence of invasive micropapillary carcinoma of the breast with different ultrasound features according to lesion site: case report. Kurume Med J. 2011;58:81–85. doi:10.2739/kurumemedj.58.81
   PubMedGoogle Scholar
• Choi JS, Han B-K, Ko EY, Ko ES, Shin JH, Kim GR. Additional diagnostic value of shear-wave elastography and color Doppler US for evaluation of breast non-mass lesions detected at B-mode US. Eur Radiol. 2016;26:3542–3549. doi:10.1007/s00330-015-4201-6
   PubMed Web of Science ®Google Scholar
• Pan LJ, Xiao Y. Ultrasonic elastography diagnosis of special type breast cancers. Chin J Med Imaging Technol. 2010;26:683–685.
   Google Scholar
• Lim HS, Kuzmiak CM, Jeong SI, et al. Invasive micropapillary carcinoma of the breast: MR imaging findings. Korean J Radiol. 2013;14:551–558. doi:10.3348/kjr.2013.14.4.551
   PubMed Web of Science ®Google Scholar
• Han CH, Yao WG, He J, Gao ZB, Hu HJ. Invasive micropapillary carcinoma of the breast: MR imaging findings. Oncol Lett. 2020;20:2811–2819. doi:10.3892/ol.2020.11848
   PubMed Web of Science ®Google Scholar
• Gandhi A, Coles C, Makris A, et al. Axillary surgery following neoadjuvant chemotherapy – Multidisciplinary Guidance From the Association of Breast Surgery, Faculty of Clinical Oncology of the Royal College of Radiologists, UK Breast Cancer Group, National Coordinating Committee for Breast. Clin Oncol. 2019;31:664–668. doi:10.1016/j.clon.2019.05.021
   PubMed Web of Science ®Google Scholar
• Dong A, Wang Y, Lu J, Zuo C. Spectrum of the breast lesions with increased 18F-FDG uptake on PET/CT. Clin Nucl Med. 2016;41:543–557. doi:10.1097/RLU.0000000000001203
   PubMed Web of Science ®Google Scholar
• Akin M, Orguc S, Aras F, Kandiloglu AR. Molecular subtypes of invasive breast cancer: correlation between PET/computed tomography and MRI findings. Nucl Med Commun. 2020;41(8):810–816. doi:10.1097/MNM.0000000000001220
   PubMed Web of Science ®Google Scholar
• Terando AM, Agnese DM, Holmes DR. Treatment and prognosis of rare breast cancers. Ann Surg Oncol. 2015;22:3225–3229. doi:10.1245/s10434-015-4748-0
   PubMed Web of Science ®Google Scholar
• Korde LA, Somerfield MR, Carey LA, et al. Neoadjuvant chemotherapy, endocrine therapy, and targeted therapy for breast cancer: ASCO guideline. J Clin Oncol. 2021:JCO.20.03399. doi:10.1200/jco.20.03399
   Web of Science ®Google Scholar
• Kim SH, Hur SM, Lee SK, et al. Characteristics of invasive micropapillary carcinoma of the breast: in comparison with invasive ductal carcinoma. J Breast Cancer. 2010;13:174–179. doi:10.4048/jbc.2010.13.2.174
   Web of Science ®Google Scholar
• Simonetti S, Dominguez N, Elguezabal A, et al. Analysis of programmed death-ligand 1 expression, stromal tumor-infiltrating lymphocytes, and mismatch repair deficiency in invasive micropapillary carcinoma of the breast. J Immunother Precis Oncol. 2019;2:130–136. doi:10.4103/JIPO.JIPO_17_19
   Google Scholar
• Wu SG, ZhangWW, Sun JY, Li FY, Chen YX, Zhen-Yu ZY. Postoperative radiotherapy for invasive micropapillary carcinoma of the breast: an analysis of surveillance, epidemiology, and end results database. Cancer Manag Res. 2017;9:453–459. doi:10.2147/CMAR.S141338
   PubMed Web of Science ®Google Scholar
• Chen H, Liang H-L, Ding A. Comparison of invasive micropapillary and triple negative invasive ductal carcinoma of the breast. Breast. 2015;24:723–731. doi:10.1016/j.breast.2015.09.001
   PubMed Web of Science ®Google Scholar
• Li D, Zhong C, Cheng YY, et al. A competing nomogram to predict survival outcomes in invasive micropapillary breast cancer. J Cancer. 2019;10:6801–6812. doi:10.7150/jca.27955
   PubMed Web of Science ®Google Scholar
• Deman F, Punie K, Laenen A, et al. Assessment of stromal tumor infiltrating lymphocytes and immunohistochemical features in invasive micropapillary breast carcinoma with long-term outcomes. Breast Cancer Res Treat. 2020;184:985–998. doi:10.1007/s10549-020-05913-x
   PubMed Web of Science ®Google Scholar
• Han Y, Wang J, Xu B. Clinicopathological characteristics and prognosis of breast cancer with special histological types: a surveillance, epidemiology, and end results database analysis. Breast. 2020;54:114–120. doi:10.1016/j.breast.2020.09.006
   PubMed Web of Science ®Google Scholar
• Li G, Yang S, Yao J, et al. Invasive micropapillary carcinoma of the breast had poor clinical characteristics but showed no difference in prognosis compared with invasive ductal carcinoma. World J Surg Oncol. 2016;14. doi:10.1186/s12957-016-0960-z
   Web of Science ®Google Scholar
• Lewis GD, Xing Y, Haque W, et al. Prognosis of lymphotropic invasive micropapillary breast carcinoma analyzed by using data from the National Cancer Database. Cancer Commun. 2019;39:1–9. doi:10.1186/s40880-019-0406-4
   Web of Science ®Google Scholar
• Liu Y, Huang X, Bi R, Yang W, Shao Z. Similar prognoses for invasive micropapillary breast carcinoma and pure invasive ductal carcinoma: a retrospectively matched cohort study in China. PLoS One. 2014;9. doi:10.1371/journal.pone.0106564
   Web of Science ®Google Scholar
• Guo X-J, Chen L, Lang R-G, Fan Y, Fu L. Relationship between lymph node metastasis and pathologic features of invasive micropapillary carcinoma of breast. Chin J Pathol. 2006;35:8–12.
   Google Scholar
• Liu F, Yang MM, Li Z, et al. Invasive micropapillary mucinous carcinoma of the breast is associated with poor prognosis. Breast Cancer Res Treat. 2015;151:443–451. doi:10.1007/s10549-015-3413-4
   PubMed Web of Science ®Google Scholar
• Wilson PC, Chagpar AB, Cicek AF, et al. Breast cancer histopathology is predictive of low-risk Oncotype Dx recurrence score. Breast J. 2018;24:976–980. doi:10.1111/tbj.13117
   PubMed Web of Science ®Google Scholar
• Kuroda H, Sakamoto G, Ohnisi K, Itoyama S. Clinical and pathologic features of invasive micropapillary carcinoma. Breast Cancer. 2004;11:169–174. doi:10.1007/BF02968297
   PubMedGoogle Scholar
• Shi W-B, Yang L-J, Hu X, Zhou J, Zhang Q, Shao Z-M. Clinico-pathological features and prognosis of invasive micropapillary carcinoma compared to invasive ductal carcinoma: a population-based study from China. PLoS One. 2014;9. doi:10.1371/journal.pone.0101390
   Web of Science ®Google Scholar
• Meng X, Ma H, Yin HH, et al. Nomogram predicting the risk of locoregional recurrence after mastectomy for invasive micropapillary carcinoma of the breast. Clin Breast Cancer. 2021;21(4):e368–e376. doi:10.1016/j.clbc.2020.12.003
   PubMed Web of Science ®Google Scholar
• Song Y, Sun H, Wu K, et al. sLex expression in invasive micropapillary breast carcinoma is associated with poor prognosis and can be combined with MUC1/EMA as a supplementary diagnostic indicator. Cancer Biol Med. 2021;18:477–489. doi:10.20892/j.issn.2095-3941.2020.0422
   PubMed Web of Science ®Google Scholar
• Nassar H, Pansare V, Zhang H, et al. Pathogenesis of invasive micropapillary carcinoma: role of MUC1 glycoprotein. Mod Pathol. 2004;17:1045–1050. doi:10.1038/modpathol.3800166
   PubMed Web of Science ®Google Scholar
• Ren M, Liu F, Zhu Y, et al. Absence of caveolin-1 expression in carcinoma-associated fibroblasts of invasive micropapillary carcinoma of the breast predicts poor patient outcome. Virchows Arch. 2014;465:291–298. doi:10.1007/s00428-014-1614-6
   PubMed Web of Science ®Google Scholar
• Wendroth SM, Mentrikoski MJ, Wick MR. GATA3 expression in morphologic subtypes of breast carcinoma: a comparison with gross cystic disease fluid protein 15 and mammaglobin. Ann Diagn Pathol. 2015;19:6–9. doi:10.1016/j.anndiagpath.2014.12.001
   PubMed Web of Science ®Google Scholar
• Yamaguchi R, Tanaka M, Kondo K, et al. Characteristic morphology of invasive micropapillary carcinoma of the breast: an immunohistochemical analysis. Jpn J Clin Oncol. 2010;40:781–787. doi:10.1093/jjco/hyq056
   PubMed Web of Science ®Google Scholar
• Onder S, Fayda M, Karanlık H, et al. Loss of ARID1A expression is associated with poor prognosis in invasive micropapillary carcinomas of the breast: a clinicopathologic and immunohistochemical study with long-term survival analysis. Breast J. 2017;23:638–646. doi:10.1111/tbj.12823
   PubMed Web of Science ®Google Scholar
• Verras GI, Mulita F, Tchabashvili L, et al. A rare case of invasive micropapillary carcinoma of the breast. Menopause Review/Przegląd Menopauzalny. 2022;21(1):1-8. doi:10.5114/pm.2022.113834
   Google Scholar